Magazine - Latest Issue

Improvising Process Through Innovation

The year 2018 is inscribed to be a milestone in evolution of the pharma industry. Keeping Speed, Quality and Cost Control as an agenda the industry inferred the upliftment of technology and process to be the mantra.

Drug market innovation, advancements and technology integration in clinical processes, cost efficiencies, technology reboot in supply chain & logistics, are few such...

Change and Innovation in the Pharma Supply Chain: More of the Same in 2019?

2018 has seen some of the most fundamental changes to the pharmaceutical industry – driven by serialisation requirements in the US and EU, as there has been a seismic shift towards a more digitalised supply chain.

Transforming The Life Sciences Supply Chain Through Blockchain

Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments?

With many serialization and track & trace regulations in the compliance period, and others (e.g., EU FMD, US DSCSA) on the horizon, life sciences companies need to think beyond serialization as a core capability and ...

Capitalizing on Digital Innovation to Enhance Delivery

The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You?

Janssen Supply Chain Vice President Remo Colarusso explains how the company is pioneering high-tech new strategies to perfect an age-old mandate: better anticipating and meeting customer demand...

The Need of Innovation in the Injectable Business – a CDMO Perspective

The world of drug development and manufacturing is undergoing a change. Nowhere is this more evident than in the rapid increase in complex compounds such as biologics.

The importance of biometric functions to improving data quality in Clinical Trials

Reducing the costs associated with clinical trials is one of the pharmaceutical industry's core challenges. Running a clinical trial is incredibly expensive and if a compound fails in the late phases, it can be catastrophic for its sponsor company.

Speed, Quality and Cost - Leveraging Australia to Expedite Clinical Development

In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies, to decrease clinical study duration, and...

How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden of Data Collection

Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment and much of the symptom burden occurs outside the clinical environment.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack / Editorial Calendar please click here

For the latest visit: www.worldpharmatoday.com